Physician profile
Douglas A Young
NPI 1275590564
$1,720.44
in general payments reported to CMS, 2019-2025
16 companies · $213 in 2025
The $213 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $17.96 · 2021: $140 · 2022: $516 · 2023: $408 · 2024: $228 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $848.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $745.81 | 2019-2025 | Clareon, Rocklatan, Rhopressa |
| Heru, INC. | $253.20 | 2022 | |
| Abbvie INC. | $178.99 | 2022-2024 | Durysta, Lumigan, Vuity |
| Allergan, INC. | $135.97 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $80.37 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $53.99 | 2024-2025 | Xdemvy |
| Horizon Therapeutics Plc | $45.73 | 2022-2023 | Tepezza |
| Omeros Corporation | $36.09 | 2020-2021 | |
| Aerie Pharmaceuticals, INC. | $35.63 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $34.29 | 2021 | |
| Iridex Corporation | $28.88 | 2019 | |
| Ocular Therapeutix, INC. | $21.50 | 2022 | |
| Biotissue Holdings INC. | $20.56 | 2025 | |
| Sun Pharmaceutical Industries INC. | $19.87 | 2022 | |
| Bausch & Lomb Americas INC. | $16.29 | 2025 | Infuse |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tearlab Corp | $13.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.